Researchers Developing Canine Longevity Pill That Could Add Years to Your Dog’s Life

Every dog owner wishes their pup could grow old with them, and Science has just taken a step closer to more time with your best friend. A biotech company is now conducting research into anti-aging drugs specifically designed for dogs. Loyal, the company behind the research, was founded in 2019 by Celine Halioua, and has since made rapid advancements toward developing the first FDA-approved drug to lengthen animal lifespan. Three experimental treatments are in development, focusing on metabolic health and hormonal regulation to slow the effects of aging.

Large breeds like German shepherds have significantly shorter lifespans than smaller dogs, in part due to high levels of the hormone IGF-1. This well-studied hormone is behind rapid growth, but it may also shorten lifespan. Loyal’s large-dog drug, which will come in both injectable form and a chewable tablet, reduce this “aging hormone” in dogs over seven years old and weighing more than 40 pounds. Another drug designed specifically for senior dogs of smaller sizes, targets metabolic decline and its associated health issues. Early trials have shown no adverse effects. Amazingly, Loyal is aiming for conditional FDA approvals as early as 2026–2027.

If Loyal’s treatments prove successful, they won’t just add years to dogs’ lives. No one wants to extend the life of an unhealthy pup that could be suffering. Instead, they would add better-quality years, offering both pets and their owners more time together. And more good news: the benefits of this research may extend beyond the canine world. Because dogs share many of the same age-related diseases as humans, they serve as valuable models for human health research.

Loyal’s Mission to Extend Dog Lifespan

• Loyal is a biotech company developing anti-aging drugs for dogs.
• CEO Celine Halioua aims to give dogs more healthy years.
• The drugs focus on preventing age-related health decline.

Why Large Dogs Age Faster

• Large dog breeds often have much shorter lifespans than smaller ones.
• High levels of IGF-1 hormone contribute to faster aging.
• Loyal’s drugs target this hormone to extend life.

LOY-001 and LOY-003

• LOY-001 is an injectable given a few times a year at the vet.
• LOY-003 is a daily chewable pill for dogs over 40 pounds.
• Both are in pilot studies and could get FDA approval by 2027.

LOY-002 for Senior Dogs

• LOY-002 targets dogs aged 10 and older over 14 pounds.
• It works by improving metabolism to prevent age-related diseases.
• The large-scale trial involves over 1,200 dogs in 70 clinics.

Metabolic Health and Longevity

• Healthy metabolism helps prevent insulin resistance and disease.
• Improved metabolism supports cognitive and physical health.
• Loyal aims to reverse some effects of aging in dogs.

Potential Impact Beyond Dogs

• Dogs share similar age-related diseases with humans.
• Studying dogs may help advance human longevity research.
• Loyal’s work could inspire breakthroughs in human medicine.

The Human-Dog Bond

• Dogs provide emotional, physical, and mental health benefits.
• Owning a dog is linked to longer life and reduced disease risk.
• Loyal’s work celebrates and strengthens this bond.